Scientists at Dana-Farber Cancer Institute have discovered why diabetic-like symptoms develop in some patients given rapamycin, an immune-suppressant drug that also has shown anti-cancer activity and may even slow ageing.
Apr 3, 2012
0
0
Inhaling a concentrated cloud of insulin through the nose twice a day appears to slow - and in some cases reverse - symptoms of memory loss in people with early signs of Alzheimer's disease, a new pilot study has found.
Sep 13, 2011
0
0
A 30-minute sauna or warm bubble bath every day might help women of a certain age fend off unwanted weight gain.
Jul 3, 2024
0
0
Type 2 diabetes in young people ages 10 to19 has more than doubled in the past 20 years, yet it remains difficult for physicians to predict who will be diagnosed and who will improve with treatment. A study from the University ...
Jun 24, 2024
0
4
Nephrology researchers at UC Davis Health are shining a light on chronic kidney disease (CKD) as they investigate treatment options for impaired physical performance and exercise intolerance in chronic kidney disease patients.
Jun 8, 2023
0
5
A procedure that uses controlled electrical pulses to induce changes to the lining of the first part of the small intestine could allow patients with type 2 diabetes to stop taking insulin and still maintain glycemic control, ...
Apr 28, 2023
0
140
A new technology dubbed the "bionic pancreas" may beat standard treatment in helping people with type 1 diabetes control their blood sugar levels, a clinical trial has found.
Sep 29, 2022
0
60
(HealthDay)—The addition of subcutaneous tirzepatide versus placebo to titrated insulin glargine results in significant improvements in glycemic control among patients with type 2 diabetes and inadequate glycemic control, ...
Feb 10, 2022
0
2
Treating people with Type 2 diabetes with a new once-a-week injectable insulin therapy proved to be safe and as effective as daily insulin injections, according to the results of two international clinical trials published ...
Apr 19, 2021
0
209
(HealthDay)—Insulin infusion helps achieve glycemic targets and may reduce the risk for poor outcomes in patients with hyperglycemia and COVID-19, according to a study published online May 19 in Diabetes Care.
May 29, 2020
0
2
